Quantum
Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

Yeah, I guess, I got 60k shares

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
kykkern Member Profile
 
Followed By 0
Posts 457
Boards Moderated 0
Alias Born 05/18/17
160x600 placeholder
OncoSec To Present Data in Late-Stage Triple Negative Breast Cancer (TNBC) at the 2018 San Antonio Breast Cancer Symposium® PR Newswire (US) - 11/13/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/9/2018 4:33:12 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/8/2018 4:47:41 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/8/2018 8:25:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2018 8:23:34 AM
OncoSec Appoints Robert Ward to its Board of Directors PR Newswire (US) - 11/8/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/7/2018 12:09:26 PM
OncoSec Doses First Patient in KEYNOTE-890 Phase 2 Clinical Trial PR Newswire (US) - 11/7/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2018 8:18:29 AM
OncoSec Reports Preliminary Data from KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial of TAVO™ in Combination wit... PR Newswire (US) - 11/6/2018 8:00:00 AM
OncoSec to Host Conference Call to Review Preliminary KEYNOTE-695 Data PR Newswire (US) - 11/5/2018 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/2/2018 5:43:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2018 5:38:40 PM
OncoSec Announces Preliminary Data from KEYNOTE-695 Study Accepted for Late-Breaking Presentation at SITC Annual Meeting PR Newswire (US) - 11/2/2018 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/29/2018 5:06:01 PM
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer PR Newswire (US) - 10/29/2018 8:00:00 AM
OncoSec Announces Publication of Data in Nature Gene Therapy Demonstrating the Ability of its Newly Optimized Intratumoral IL... PR Newswire (US) - 10/24/2018 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/19/2018 5:33:42 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/19/2018 5:31:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2018 6:01:57 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/17/2018 5:11:30 PM
OncoSec Initiates KEYNOTE-890, a Phase 2 Clinical Trial of TAVO in Combination with Merck's KEYTRUDA® (pembrolizumab) for th... PR Newswire (US) - 10/15/2018 7:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/9/2018 5:30:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2018 5:21:32 PM
OncoSec Announces Closing of First Tranche of $15 Million At Market Investment from Alpha Holdings, Inc. PR Newswire (US) - 10/9/2018 8:00:00 AM
kykkern   Friday, 02/09/18 05:38:35 PM
Re: trading.jeff post# 43022
Post # of 45709 
Yeah, I guess, I got 60k shares

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist